Open access · US-GOV
via ClinicalTrials.gov Clinical trial
Investigation of the Maximal Treatment Interval and Long-term Remission and the Associated Factors of Neovascular AMD Treated With Anti-VEGF Using Treat and Extend Strategy
Authors not listed
Shin Kong Wu Ho-Su Memorial Hospital · 2022
Abstract
To evaluate the duration of effectiveness of anti-VEGF (Aflibercept) by analyzing the percentage of patients whose maximum treatment interval is extended to 16 weeks and beyond in 24 months and their long-term remission.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- ClinicalTrials.gov
- Canonical
- link ↗
- Fetched
- 2026-11-12 MST
Cite this
APA
Anonymous. (2022). Investigation of the Maximal Treatment Interval and Long-term Remission and the Associated Factors of Neovascular AMD Treated With Anti-VEGF Using Treat and Extend Strategy. <em>Shin Kong Wu Ho-Su Memorial Hospital</em>. https://clinicaltrials.gov/study/NCT05342857
Vancouver
Anonymous. Investigation of the Maximal Treatment Interval and Long-term Remission and the Associated Factors of Neovascular AMD Treated With Anti-VEGF Using Treat and Extend Strategy. Shin Kong Wu Ho-Su Memorial Hospital. 2022.
BibTeX
@misc{anon2022Invest,
title = {Investigation of the Maximal Treatment Interval and Long-term Remission and the Associated Factors of Neovascular AMD Treated With Anti-VEGF Using Treat and Extend Strategy},
author = {Anonymous},
journal = {Shin Kong Wu Ho-Su Memorial Hospital},
year = {2022},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
Clinical Therapeutics 2015
Citation only
The Pathophysiology and Treatment of Osteoporosis
PLoS ONE 2020
Open access · CC-BY
Hydrogen extends Caenorhabditis elegans longevity by reducing reactive oxygen species
Nippon Ronen Igakkai Zasshi Japanese Journal of Geriatrics 1990
Open access · OA
Effect of aging on bone mineral content. part VII. The evaluation of osteoporosis treatment by the measurement of total body bone mineral content using dual photon absorptiometery.
Elsevier eBooks 2006
Citation only
Age-Related Osteoporosis and Skeletal Markers of Bone Turnover
Journal of Osteoporosis and Physical Activity 2018
Open access · OA
Association of Young Age with Bone Mineral Density Improvement with Denosumab Treatment in Patients with Osteoporosis
Nanjing Medical University 2021
Open access · US-GOV